Payer

Humana and Cigna joined Aetna in waiving cost-sharing for treatment related to COVID-19, the health insurers said March 30. 

Blue Cross Blue Shield of North Carolina said it will cover two drugs currently being investigated as possible treatments for COVID-19 patients: hydroxychloroquine and chloroquine, according to The Charlotte Observer. 

UnitedHealth Group plans to launch a self-administered COVID-19 test in an effort to reduce risk to healthcare workers who are running short on personal protective equipment, according to The Wall Street Journal.

UnitedHealth Group plans to invest an initial $50 million to fight the COVID-19 pandemic, the health insurance giant said March 26. 

CVS Health-owned Aetna will waive copays and cost-sharing for COVID-19 inpatient hospitalizations, the insurer said March 25.

More health insurance scams and misleading marketing for short-term health plans is cropping up amid the COVID-19 outbreak. 

Houston-based Memorial Hermann Health System and Cigna agreed to extend their contract again as the U.S. deals with a growing COVID-19 outbreak, according to the Houston Chronicle.

Health insurers should direct premium dollars to providers who are on the front lines of the COVID-19 pandemic now, two academics wrote in an op-ed for the Harvard Business Review.

Fitch Ratings revised its stable outlook for the U.S. health insurance industry to negative due to adverse effects from the COVID-19 outbreak. 

Michael Neidorff, the CEO of Centene Corp., took home more than $26 million for the second year in a row, according to the St. Louis Post-Dispatch.